Statement of Changes in Stockholders'Deficit - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2013	$ 267	$ 366,083	$ (801,203)	$ (434,853)
Balance (in shares) at Dec. 31, 2013	2,666,666
Increase Decrease In Stockholders Equity Roll Forward
Stock-based compensation		164,156		164,156
Conversion of notes payable into common stock	$ 21	524,979		525,000
Conversion of notes payable into common stock (in shares)	207,664
Beneficial conversion feature on issuance of convertible promissory notes		614,557		614,557
Warrants issued, line of credit		114,300		114,300
Warrant, transfer agreement		37,840		37,840
Deemed dividends on redeemable convertible preferred stock		(610,889)		(610,889)
Accretion of issuance costs		(35,784)		(35,784)
Net loss and comprehensive loss			(8,609,575)	(8,609,575)
Balance at Dec. 31, 2014	$ 288	1,175,242	(9,410,778)	(8,235,248)	[1]
Balance (in shares) at Dec. 31, 2014	2,874,330
Increase Decrease In Stockholders Equity Roll Forward
Stock-based compensation		52,617		52,617
Beneficial conversion feature on issuance of convertible promissory notes		202,521		202,521
Deemed dividends on redeemable convertible preferred stock		(177,297)		(177,297)
Accretion of issuance costs		(9,789)		(9,789)
Napo license fee abatement		250,000		250,000
Net loss and comprehensive loss			(3,937,383)	(3,937,383)
Balance at Mar. 31, 2015	$ 288	$ 1,493,294	$ (13,348,161)	$ (11,854,579)
Balance (in shares) at Mar. 31, 2015	2,874,330

[1] The condensed balance sheet at December 31, 2014 is derived from the audited financial statements at that date included in the Company's prospectus filed with the Securities and Exchange Commission pursuant to rule 424 (b)(4)on May 14, 2015.